Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 97-108 of 23,847
Drug study icon
RecruitingNCT07225712

A Long-term Administration study of SEP-363856 in people with Schizophrenia

This study is looking at whether SEP-363856 can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

In Fukuoka
SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Schizophrenia
Drug study icon
RecruitingNCT06926829

A Long-term study of EB-1020 in adults with ADHD

4 mg can help people with Attention Deficit Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

In Tokyo
ADHDDrugFrom 18 Years to 55 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Drug study icon
RecruitingNCT07087327

A Long-term study of EB-1020 in Pediatric people with ADHD

This study is looking at evaluate the safety of long-term administration of mainly high doses of EB-1020 over 52 weeks in pediatric ADHD patients for people with Attention-Deficit Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

In Sapporo
ADHDDrugFrom 6 Years to 17 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Other study type icon
RecruitingISRCTN97264476

A Loving Kindness Meditation program for people with persistent depressive disorder

This study is looking at whether a digital support tool can help people with Chronic depression / Persistent depression or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.

In Germany
DepressionOtherOver 18 Years
Countries
Germany
Sponsor
Goethe University.Frankfurt
Condition
Depression
Behavioral study icon
RecruitingNCT06441786

A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism

This study is looking at whether A metacognitive group therapy of depression and anxiety in youth with autism can help people with anxiety or depression. Participants take part in A metacognitive group therapy of depression and anxiety in youth with autism and complete follow-up assessments.

In Haninge
Anxiety, DepressionBehavioralFrom 15 Years to 18 Years
Countries
Sweden
Sponsor
Uppsala University
Condition
Anxiety, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.